Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts
Ashot Avagimyan(Isfahan University of Medical Sciences), Nizal Sarrafzadegan(Isfahan University of Medical Sciences), Lusine Mkrtchyan(Yerevan State Medical University), Mattía Galli(Maria Cecilia Hospital), Davood Shafie(Isfahan University of Medical Sciences), Zinaida Jndoyan(Yerevan State Medical University), Л.М. Михалева(Research Institute of Human Morphology), Е А Коган(Sechenov University), Nana Pogosova(National Medical Research Center of Cardiology), О. И. Уразова(Siberian State Medical University), А. И. Трофименко(Kuban State Medical University), Luciano Agati(Policlinico Umberto I), Arrigo F.G. Cicero(Istituto delle Scienze Neurologiche di Bologna), Zhanna Kobalava(Peoples' Friendship University of Russia), Federica Fogacci(Atatürk University), Lev Kakrurskiy(Research Institute of Human Morphology), Gioeva Zarina(Research Institute of Human Morphology), Karmen Saahakyan(Policlinico Umberto I), Giovanni Di Salvo(NIHR Imperial Biomedical Research Centre), Rositsa Vandysheva(Research Institute of Human Morphology), Anait Aznauryan(Yerevan State Medical University), Grizelda Navasardyan(Yerevan State Medical University)
Cited by 42
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
|Archives of Medical Science|2017|288
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
|Nutrition Reviews|2017|286